Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is ...

For some people, diet, and exercise are not enough to lose weight and keep it off. This is where weight loss medication, ...

Takeda and Orexigen have been given FDA clearance to market their obesity treatment Contrave – but sales of the drug will be curtailed ... to a reduced-calorie diet and increased physical ...

It outperformed Orexigen's Mysimba/Contrave weight loss drug, where around a quarter of patients in a phase 3 trial achieved the target. Semaglutide came out top of the analysis, with 63% of ...

The researchers compared the drugs to bupropion-naltrexone, the active ingredient in weight-loss drug Contrave, which was approved in 2014. A Novo Nordisk spokesperson noted that some of the ...

Ro breaks down the details and effectiveness of the best prescription weight loss pills. Obesity is a chronic medical condition that affects millions of people worldwide. And while BMI (body mass ...